Summary Statement: The Sygen® (GM-1 Ganglioside) Clinical Trial in Acute Spinal Cord Injury
Fehlings M, Bracken M. Summary Statement: The Sygen® (GM-1 Ganglioside) Clinical Trial in Acute Spinal Cord Injury. Spine 2001, 26: s99-s100. PMID: 11805615, DOI: 10.1097/00007632-200112151-00016.Commentaries, Editorials and Letters